Securities Code: 301211 Securities Abbreviation: Hengdi Pharmaceutical Announcement No.: 2026-030
Hubei Hengdi Pharmaceutical Co., Ltd.
Announcement of Resolutions of the First Meeting of the Third Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or significant omissions.
I. Convening of the Board Meeting
The first meeting of the third Board of Directors of Hubei Hengdi Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was delivered to all directors via telephone and email on June 11, 2026. The meeting was held in person and via communication on June 17, 2026. A total of 8 directors were eligible to attend, and 8 directors actually attended. The meeting was presided over by Mr. Cheng Zhigang, Chairman of the Company. Senior management personnel of the Company attended the meeting as non-voting participants. The convocation, convening, and voting procedures of this Board meeting comply with the relevant provisions of the Company Law of the People's Republic of China and the Articles of Association. The meeting was legal and valid.
II. Deliberation of Board Meeting Matters
The meeting deliberated and approved the following proposals:
- Proposal on the Election of the Chairman of the Board
The Board of Directors agreed to elect Mr. Cheng Zhigang as the Chairman of the third Board of Directors and the Legal Representative of the Company. His term of office is three years, commencing from the date of approval of this Board meeting until the expiration of the term of the third Board of Directors. For detailed content, please refer to the "Announcement on the Election of the Board of Directors and the Appointment of Senior Management, Chief Financial Officer, Securities Affairs Representative, and Head of Internal Audit" disclosed by the Company on the same day on the Juchao Information Network (http://www.cninfo.com.cn).
This proposal has been reviewed and approved by the Nomination Committee of the Board.
Voting Results: 7 votes in favor, 0 votes against, 0 abstentions, 1 recusal.
Director Cheng Zhigang was a candidate and had a conflict of interest, thus abstaining from voting.
- Proposal on the Election of Members of the Board's Specialized Committees